Welcome to Psilocybin Podcast, where we explore the world of mental health and alternative treatments. In today's episode, we are diving into the fascinating realm of psilocybin, a compound found in magic mushrooms. I'm your host, Mark Leeds, D.O., and I've been eager to create this podcast to shed light on the potential benefits of psilocybin in the treatment of various mental health conditions, such as depression. We'll be discussing the use of psilocybin as an alternative to traditional antidepressants. It's truly remarkable to see the power of this medication when used in a clinical setting under specific protocols. Although not currently FDA-approved, psilocybin is permitted for research purposes and has even been decriminalized in some regions. We'll delve into the corporate landscape and the growing interest in producing synthetic psilocybin as an FDA-approved medication. Join us as we explore the intricacies of drug scheduling and how psilocybin may potentially move from a Schedule 1 drug to a lower schedule, opening up more possibilities for its use. We'll also examine the historical context of psychedelics and the need for responsible usage under supervision. As we navigate this exciting field of psychedelic-assisted therapy, we invite you to share your interests and suggestions for future episodes and guest interviews. Whether you're an expert in the field or a listener with a curious mind, we're excited to embark on this journey together on The Rehab: Psilocybin Podcast. Thank you for joining us!